Results 161 to 170 of about 17,431 (301)

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery

open access: yesFrontiers in Immunology
Onco-virotherapy is an emergent treatment for cancer based on viral vectors. The therapeutic activity is based on two different mechanisms including tumor-specific oncolysis and immunostimulatory properties.
Hélène Lê   +11 more
doaj   +1 more source

Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus

open access: yesStem Cells International, 2017
Antitumor efficacy of systemically administered oncolytic adenoviruses (OAdv) is limited due to diverse factors such as liver sequestration, neutralizing interactions in blood, elimination by the immune system, and physical barriers in tumors.
R. Moreno   +6 more
doaj   +1 more source

Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions

open access: yesViruses, 2015
Oncolytic virotherapy for cancer is an innovative therapeutic option where the ability of a virus to promote cell lysis is harnessed and reprogrammed to selectively destroy cancer cells.
Janice Kim   +3 more
doaj   +1 more source

Oncolytic Viroradiotherapy for Neuroblastoma [PDF]

open access: yes, 2014
College of Education and Human Ecology Undergraduate Research ScholarshipNeuroblastoma is the most common extra-cranial solid tumor in childhood and the leading cause of childhood cancer mortality.
Kunkler, Anne
core  

77. Production and Purification of Measles Virus for Oncolytic Virotherapy Clinical Trials [PDF]

open access: hybrid, 2004
Dhanalakshmi Chinnasamy   +5 more
openalex   +1 more source

327. Retargetable Oncolytic Measles Viruses for Cancer Virotherapy [PDF]

open access: hybrid, 2004
Takafumi Nakamura   +3 more
openalex   +1 more source

Effective gene–virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5 [PDF]

open access: hybrid, 2005
Xin‐Yuan Liu   +9 more
openalex   +1 more source

ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: To describe a case of choroidal melanoma treated with Rigvir® virotherapy in an adjuvant setting. Observations: A female patient born in 1956 presented with a small choroidal melanoma in October 2007. 34 months after transpupillary thermotherapy
Inta Jaunalksne   +4 more
doaj  

Literature review: Virus and cancer [PDF]

open access: yes, 2017
Traballo fin de grao (UDC.CIE). Bioloxía. Curso 2016/2017[Abstract] Cancer is one of the main causes of global mortality, and even though it is considered to be a non-communicable disease, several infectious agents have been found to contribute to ...
Carreira Santos, Sofía
core  

Home - About - Disclaimer - Privacy